Adherence to Aromatase Inhibitors: The Role of Partners

• Sponsor: Abramson Cancer Center of the University of Pennsylvania (Other)
• Overall Status: Completed
• CT.gov ID: NCT02753985
• Collaborator: (none)
• Enrollment: 40
• Location: 1
• Duration (Months): 21.7
• Patients Per Site Per Month: 1.8

Study Details

Study Description

Brief Summary

This is a qualitative study which explores the role that partners play in breast cancer survivors adherence to aromatase inhibitors and management of their side effects. Both patients and their partners will be interviewed (separately) in order to capture multiple perspectives. The target number of subjects is 64 (32 patients and 32 partners). The primary method of data collection will be face-to-face semi-structured interviews. These interviews will be audio-recorded.

Condition or Disease	Intervention/Treatment	Phase
Breast Cancer Survivors	Other: Survey

Study Design

• Study Type: Observational
• Actual Enrollment: 40 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: Adherence to Aromatase Inhibitors: The Role of Partners
• Study Start Date: Jul 1, 2014
• Actual Primary Completion Date: Apr 22, 2016
• Actual Study Completion Date: Apr 22, 2016

Outcome Measures

Primary Outcome Measures

1. Number of Surveys Completed [2 years]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: Female
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• Women and partners of women with stage I-III breast cancer who

1. have completed primary cancer treatments (surgery, chemotherapy, radiotherapy)

2. have experienced AI side effects

3. live with a romantic partner.

Exclusion Criteria:

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Abramson Cancer Center of the University of Pennsylvania	Philadelphia	Pennsylvania	United States	19104

Sponsors and Collaborators

• Abramson Cancer Center of the University of Pennsylvania

Investigators

• Principal Investigator: Jun Mao, MD, Abramson Cancer Center of the University of Pennsylvania

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Abramson Cancer Center of the University of Pennsylvania
• ClinicalTrials.gov Identifier: NCT02753985
• Other Study ID Numbers: UPCC 15114
• First Posted: Apr 28, 2016
• Last Update Posted: Jul 23, 2019
• Last Verified: Jul 1, 2019

Study Results

No Results Posted as of Jul 23, 2019